Produktname:3-amino-1-propan-2-ylpyrazole-4-carbonitrile

IUPAC Name:3-amino-1-(propan-2-yl)-1H-pyrazole-4-carbonitrile

CAS:89897-29-0
Molekulare Formel:C7H10N4
Reinheit:95%+
Katalognummer:CM336694
Molekulargewicht:150.19

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM336694-1g in stock ƱȦƻ
CM336694-5g in stock ƋƱſ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:89897-29-0
Molekulare Formel:C7H10N4
Schmelzpunkt:-
SMILES-Code:N#CC1=CN(C(C)C)N=C1N
Dichte:
Katalognummer:CM336694
Molekulargewicht:150.19
Siedepunkt:
Mdl-Nr.:
Lagerung:

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.

Column Infos

Encorafenib plus Binimetinib
U.S. FDA approved Pfizer's BRAFTOVI® (Encorafenib) + MEKTOVI® (Binimetinib) for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. The FDA's approval is based on data from the ongoing Phase 2 PHAROS clinical trial. Encorafenib is an oral small molecule BRAF kinase inhibitor, and Binimetinib is an oral small molecule MEK inhibitor targeting key proteins in the MAPK signaling pathway (RAS-RAF-MEK-ERK).
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.